HDAC inhibition potentiates immunotherapy in triple negative breast cancer

Triple-negative breast cancer (TNBC) represents a more aggressive and difficult subtype of breast cancer where responses to chemotherapy occur, but toxicity is significant and resistance often follows. Immunotherapy has shown promising results in various types of cancer, including breast cancer. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Terranova-Barberio, Manuela, Thomas, Scott, Ali, Niwa, Pawlowska, Nela, Park, Jeenah, Krings, Gregor, Rosenblum, Michael D., Budillon, Alfredo, Munster, Pamela N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768393/
https://www.ncbi.nlm.nih.gov/pubmed/29371976
http://dx.doi.org/10.18632/oncotarget.23169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768393/
https://www.ncbi.nlm.nih.gov/pubmed/29371976
http://dx.doi.org/10.18632/oncotarget.23169

Ejemplares similares